Annual CFO:
-$167.65M-$179.57M(-1506.55%)Summary
- As of today, AMLX annual cash from operations is -$167.65 million, with the most recent change of -$179.57 million (-1506.55%) on December 31, 2024.
- During the last 3 years, AMLX annual cash from operations has fallen by -$92.85 million (-124.13%).
- AMLX annual cash from operations is now -1506.55% below its all-time high of $11.92 million, reached on December 31, 2023.
Performance
AMLX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$25.25M+$14.58M(+36.60%)Summary
- As of today, AMLX quarterly cash from operations is -$25.25 million, with the most recent change of +$14.58 million (+36.60%) on June 1, 2025.
- Over the past year, AMLX quarterly cash from operations has increased by +$41.33 million (+62.08%).
- AMLX quarterly cash from operations is now -286.32% below its all-time high of $13.55 million, reached on December 31, 2023.
Performance
AMLX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$165.65M+$41.33M(+19.97%)Summary
- As of today, AMLX TTM cash from operations is -$165.65 million, with the most recent change of +$41.33 million (+19.97%) on June 1, 2025.
- Over the past year, AMLX TTM cash from operations has dropped by -$106.96 million (-182.26%).
- AMLX TTM cash from operations is now -1103.82% below its all-time high of $16.50 million, reached on March 31, 2024.
Performance
AMLX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AMLX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -1506.5% | +62.1% | -182.3% |
| 3Y3 Years | -124.1% | +45.7% | -90.2% |
| 5Y5 Years | -1468.7% | - | - |
AMLX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
| 5Y | 5-Year | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
| All-Time | All-Time | -1506.5% | +6.8% | -286.3% | +62.1% | -1103.8% | +20.0% |
AMLX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$25.25M(+36.6%) | -$165.65M(+20.0%) |
| Mar 2025 | - | -$39.82M(+32.5%) | -$206.98M(-23.5%) |
| Dec 2024 | -$167.65M(-1506.6%) | -$59.01M(-41.9%) | -$167.65M(-76.3%) |
| Sep 2024 | - | -$41.57M(+37.6%) | -$95.09M(-62.0%) |
| Jun 2024 | - | -$66.58M(>-9900.0%) | -$58.69M(-455.6%) |
| Mar 2024 | - | -$489.00K(-103.6%) | $16.50M(+38.5%) |
| Dec 2023 | $11.92M | $13.55M(+362.2%) | $11.92M(+123.2%) |
| Sep 2023 | - | -$5.17M(-160.0%) | -$51.33M(+42.5%) |
| Jun 2023 | - | $8.61M(+269.7%) | -$89.24M(+38.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$5.07M(+89.8%) | -$144.31M(+19.8%) |
| Dec 2022 | -$179.87M(-140.5%) | -$49.70M(-15.4%) | -$179.87M(-38.2%) |
| Sep 2022 | - | -$43.08M(+7.3%) | -$130.17M(-49.5%) |
| Jun 2022 | - | -$46.46M(-14.3%) | -$87.10M(-62.2%) |
| Mar 2022 | - | -$40.63M(-211.4%) | -$53.68M(-109.0%) |
| Dec 2021 | -$74.80M(-103.8%) | - | - |
| Jun 2021 | - | -$13.05M(-3.2%) | -$25.69M(-103.2%) |
| Mar 2021 | - | -$12.64M | -$12.64M |
| Dec 2020 | -$36.70M(-243.4%) | - | - |
| Dec 2019 | -$10.69M | - | - |
FAQ
- What is Amylyx Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Amylyx Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Amylyx Pharmaceuticals, Inc.?
- What is Amylyx Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Amylyx Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of AMLX is -$167.65M
What is the all-time high annual cash from operations for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high annual cash from operations is $11.92M
What is Amylyx Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, AMLX annual cash from operations has changed by -$179.57M (-1506.55%)
What is Amylyx Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of AMLX is -$25.25M
What is the all-time high quarterly cash from operations for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high quarterly cash from operations is $13.55M
What is Amylyx Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, AMLX quarterly cash from operations has changed by +$41.33M (+62.08%)
What is Amylyx Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of AMLX is -$165.65M
What is the all-time high TTM cash from operations for Amylyx Pharmaceuticals, Inc.?
Amylyx Pharmaceuticals, Inc. all-time high TTM cash from operations is $16.50M
What is Amylyx Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, AMLX TTM cash from operations has changed by -$106.96M (-182.26%)